There are always risks, and ignoring a novel approach is also a risk. The issue is to gauge risk intelligently, based on extensive prior medical, biological and

There are always risks, and ignoring a novel approach is also a risk. The issue is to gauge risk intelligently, based on extensive prior medical, biological and physicochemical knowledge and modelling, and on sound clinical testing using randomized controlled trials (the kind of trial that proved dexametasone and disproved ivermectin, hydroxyquinoline etc. as a therapeutic for covid).